Results 141 to 150 of about 58,085 (295)
Heart failure and dipeptidyl peptidase‐4 inhibitors [PDF]
European Journal of Heart Failure, 2014 Henry, Krum +3 more
openaire +2 more sources
Saxagliptin for type 2 diabetes
Diabetes, Metabolic Syndrome and Obesity, 2010 Antonio R Chacra, MDDiabetes Center, Federal University of São Paulo, BrazilAbstract: Saxagliptin (Onglyza™) is a potent, selective, once-daily dipeptidyl peptidase-4 (DPP-4) inhibitor indicated for improving glycemic control in patients ...
Chacra
doaj +2 more sources
Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study [PDF]
, 2020 Yi-Chuan Chen +6 more
openalex +1 more source
CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation† [PDF]
, 2017 OBJECTIVES The CD26 antigen is a transmembrane glycoprotein that is constitutively expressed on activated lymphocytes and in pulmonary parenchyma. This molecule is also identified as dipeptidyl peptidase-4 (DPP-4) that cleaves a host of biologically ...
Arni, Stephan +5 more
core
Dipeptidyl Peptidase 4 Inhibitor, an Update [PDF]
The Journal of Korean Diabetes, 2021 openaire +1 more source
Dipeptidyl peptidase-4 inhibitors and osteoporosis
Journal of the Chinese Medical Association, 2022 Wen-Ling Lee, Fa-Kung Lee, Peng-Hui Wang
openaire +1 more source
Thalidomide and a Dipeptidyl Peptidase 4 Inhibitor in a Rat Model of Experimental Autoimmune Myocarditis. [PDF]
Korean Circ J, 2023 Kim KJ, Park JB, Lee SP, Kim HK, Kim YJ.
europepmc +1 more source